Peabody

Peabody Pharmaceuticals is a clinical-stage biotechnology company dedicated to developing innovative drug delivery solutions for high-unmet-need areas, particularly acute pain and neuro-oncology. Headquartered in Baltimore and closely affiliated with Johns Hopkins University, the company leverages proprietary lipid and polymer-based carrier systems to enhance the safety and efficacy of established therapeutics. Its lead program focuses on translating Ethiqa XR, an FDA-approved veterinary extended-release buprenorphine, into a human treatment for acute pain with a significantly lower risk of abuse and addiction. Additionally, Peabody is advancing a pipeline of non-viral nanoparticle-based gene therapies and localized delivery systems for the treatment of aggressive brain tumors such as glioblastoma. By combining advanced materials science with proven pharmacological agents, the company aims to address the dual challenges of the opioid crisis and treatment-resistant cancers.